Literature DB >> 21497101

Development and verification of THORplan--a BNCT treatment planning system for THOR.

Tzung-Yi Lin1, Yen-Wan Hsueh Liu.   

Abstract

THORplan is a treatment planning system under continuous development and refinement at Tsing Hua University, Taiwan, for BNCT purpose. New features developed for homogeneous model calculation include material grouping model, and voxel data reconstruction model. Material grouping model is a two-step grouping method, tissue-volume-percent grouping method followed by atom-gram-density grouping method. The root mean square difference of neutron flux due to material grouping is <0.8%. In the voxel data reconstruction model, voxel neutron dose is calculated based on the material composition and dose of individual atom of each voxel, which is calculated by linear interpolation from the dose of individual atom of neighboring cells tallied in MCNP calculation. The detailed voxel model is used to benchmark the accuracy of the new features developed for the homogeneous model calculation. The maximum error of the neutron flux and dose of voxels using the homogeneous cell model is 5% and 7%, respectively. Big improvement of accuracy of voxel dose over the original dose calculation model based on F6 tally is observed at locations containing very heterogeneous compositions. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Mesh:

Year:  2011        PMID: 21497101     DOI: 10.1016/j.apradiso.2011.03.025

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  4 in total

1.  Boron delivery with liposomes for boron neutron capture therapy (BNCT): biodistribution studies in an experimental model of oral cancer demonstrating therapeutic potential.

Authors:  Elisa M Heber; Peter J Kueffer; Mark W Lee; M Frederick Hawthorne; Marcela A Garabalino; Ana J Molinari; David W Nigg; William Bauer; Andrea Monti Hughes; Emiliano C C Pozzi; Verónica A Trivillin; Amanda E Schwint
Journal:  Radiat Environ Biophys       Date:  2012-01-21       Impact factor: 1.925

2.  Biodistribution of sodium borocaptate (BSH) for boron neutron capture therapy (BNCT) in an oral cancer model.

Authors:  Marcela A Garabalino; Elisa M Heber; Andrea Monti Hughes; Sara J González; Ana J Molinari; Emiliano C C Pozzi; Susana Nievas; Maria E Itoiz; Romina F Aromando; David W Nigg; William Bauer; Verónica A Trivillin; Amanda E Schwint
Journal:  Radiat Environ Biophys       Date:  2013-04-17       Impact factor: 1.925

Review 3.  Clinical trials for treating recurrent head and neck cancer with boron neutron capture therapy using the Tsing-Hua Open Pool Reactor.

Authors:  Ling-Wei Wang; Yen-Wan Hsueh Liu; Fong-In Chou; Shiang-Huei Jiang
Journal:  Cancer Commun (Lond)       Date:  2018-06-19

4.  A comparison of dose distributions in gross tumor volume between boron neutron capture therapy alone and combined boron neutron capture therapy plus intensity modulation radiation therapy for head and neck cancer.

Authors:  Jia-Cheng Lee; Keh-Shih Chuang; Yen-Wan Hsueh Liu; Tzung-Yi Lin; Yi-Chiao Teng; Ling-Wei Wang
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.